Live attenuated SARS-CoV-2 vaccine candidate shows protective efficacy in vivo

By | February 19, 2021
A new preprint on the bioRxiv* server describes the development of a live attenuated vaccine candidate to counter the growing threat of the COVID-19 pandemic.